APOE and Alzheimer disease: In this study, we hypothesized that the differences of oxidative stress and mtDNA copy number levels found in patients carrying different allele genotypes of APOE could be applied as biomarkers to predict the onset of AD and to measure the effectiveness of therapeutic interventions.